» Articles » PMID: 32956401

A Plasmodium Cysteine Protease Required for Efficient Transition from the Liver Infection Stage

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2020 Sep 21
PMID 32956401
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The transitions between developmental stages are critical points in the Plasmodium life cycle. The development of Plasmodium in the livers of their mammalian hosts bridges malaria transmission and the onset of clinical symptoms elicited by red blood cell infection. The egress of Plasmodium parasites from the liver must be a carefully orchestrated process to ensure a successful switch to the blood stage of infection. Cysteine protease activity is known to be required for liver-stage Plasmodium egress, but the crucial cysteine protease(s) remained unidentified. Here, we characterize a member of the papain-like cysteine protease family, Plasmodium berghei serine repeat antigen 4 (PbSERA4), that is required for efficient initiation of blood-stage infection. Through the generation PbSERA4-specific antisera and the creation of transgenic parasites expressing fluorescently tagged protein, we show that PbSERA4 is expressed and proteolytically processed in the liver and blood stages of infection. Targeted disruption of PbSERA4 results in viable and virulent blood-stage parasites. However, upon transmission from mosquitoes to mice, Pbsera4(-) parasites displayed a reduced capacity to initiate a new round of asexual blood-stage replication. Our results from cultured cells indicate that this defect results from an inability of the PbSERA4-deficient parasites to egress efficiently from infected cells at the culmination of liver-stage development. Protection against infection with wildtype P. berghei could be generated in animals in which Pbsera4(-) parasites failed to establish infection. Our findings confirm that liver-stage merozoite release is an active process and demonstrate that this parasite-encoded cysteine protease contributes to parasite escape from the liver.

Citing Articles

To quest new targets of parasite and their potential inhibitors to combat antimalarial drug resistance.

Biswas P, Roy R, Ghosh K, Nath D, Samadder A, Nandi S J Parasit Dis. 2024; 48(4):671-722.

PMID: 39493470 PMC: 11527868. DOI: 10.1007/s12639-024-01687-x.


Targeting the proteome and organelles for potential antimalarial drug candidates.

Abugri J, Ayariga J, Sunwiale S, Wezena C, Gyamfi J, Adu-Frimpong M Heliyon. 2022; 8(8):e10390.

PMID: 36033316 PMC: 9398786. DOI: 10.1016/j.heliyon.2022.e10390.


Dissecting disease tolerance in Plasmodium vivax malaria using the systemic degree of inflammatory perturbation.

Vinhaes C, Carmo T, Queiroz A, Fukutani K, Araujo-Pereira M, Arriaga M PLoS Negl Trop Dis. 2021; 15(11):e0009886.

PMID: 34727121 PMC: 8589215. DOI: 10.1371/journal.pntd.0009886.


Autocatalytic activation of a malarial egress protease is druggable and requires a protein cofactor.

Tan M, Koussis K, Withers-Martinez C, Howell S, Thomas J, Hackett F EMBO J. 2021; 40(11):e107226.

PMID: 33932049 PMC: 8167364. DOI: 10.15252/embj.2020107226.


Malaria parasite egress at a glance.

Tan M, Blackman M J Cell Sci. 2021; 134(5).

PMID: 33686010 PMC: 7610674. DOI: 10.1242/jcs.257345.

References
1.
Suarez C, Volkmann K, Gomes A, Billker O, Blackman M . The malarial serine protease SUB1 plays an essential role in parasite liver stage development. PLoS Pathog. 2013; 9(12):e1003811. PMC: 3861531. DOI: 10.1371/journal.ppat.1003811. View

2.
Aly A, Matuschewski K . A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts. J Exp Med. 2005; 202(2):225-30. PMC: 2213010. DOI: 10.1084/jem.20050545. View

3.
Lasonder E, Rijpma S, van Schaijk B, Hoeijmakers W, Kensche P, Gresnigt M . Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes: molecular insight into sex-specific processes and translational repression. Nucleic Acids Res. 2016; 44(13):6087-101. PMC: 5291273. DOI: 10.1093/nar/gkw536. View

4.
Glushakova S, Mazar J, Hohmann-Marriott M, Hama E, Zimmerberg J . Irreversible effect of cysteine protease inhibitors on the release of malaria parasites from infected erythrocytes. Cell Microbiol. 2008; 11(1):95-105. PMC: 2883916. DOI: 10.1111/j.1462-5822.2008.01242.x. View

5.
Sturm A, Amino R, van de Sand C, Regen T, Retzlaff S, Rennenberg A . Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science. 2006; 313(5791):1287-90. DOI: 10.1126/science.1129720. View